Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review [PDF]
Journal of International Medical Research, 2019 Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti ...
Horace Massa +5 more
doaj +5 more sources
Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair [PDF]
Türk Oftalmoloji Dergisi, 2018 Cystoid macular oedema (CMO) is one of the most frequent postoperative macular complications to cause partial visual recovery after successful retinal detachment (RD) repair.
Fadi Alfaqawi +4 more
doaj +5 more sources
Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review [PDF]
Ophthalmology and Therapy, 2018 Diabetic macular edema (DMO) is a leading cause of blindness in the working age population. Although anti-vascular endothelial growth factor (VEGF) therapy provided a major advance in treatment of DMO for many patients, there is a significant proportion ...
William Fusi-Rubiano +4 more
doaj +4 more sources
Intravitreal Therapy for Diabetic Macular Edema: An Update [PDF]
Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021 Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight-Threatening condition, it is also among the most accessible to treatment.
Alessio G. +3 more
core +2 more sources
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review
Journal of Ophthalmology, 2021 Corticosteroids are used in a variety of ophthalmological diseases. One challenge faced by ophthalmologists is to deliver corticosteroids to the posterior segment of the eye with efficacy and safety.
Flávio Ribeiro, Manuel S. Falcão
doaj +2 more sources
Micro-implant d'acétonide de fluocinolone (ILUVIEN(®)) pour l'oedème maculaire diabétique chronique [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema]. [PDF]
Journal Français d'Ophtalmologie, 2015 Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy and may cause severe visual loss. In this article, we examine the pathophysiology of DME and review various treatment options, such as laser photocoagulation, anti-vascular ...
Behar-Cohen, F., Soubrane, G.
core +3 more sources
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series [PDF]
European Journal of Neurology, Volume 29, Issue 10, Page 3028-3038, October 2022., 2022 Background and purpose: Approximately 1% of patients with multiple sclerosis (MS) have uveitis, but data on the effects of immunotherapies for MS on MS-associated uveitis are scarce.
Meisel, Andreas +5 more
core +2 more sources
Ophthalmology and TherapyIntroduction Diabetic macular edema (DME) imposes a substantial clinical and psychosocial burden on patients and caregivers due to frequent visits and intravitreal treatments.
João Alves-Ambrósio +4 more
doaj +2 more sources
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) [PDF]
Ophthalmic Research, 2017 PURPOSE: The aim of this study was to assess the effectiveness and safety of ILUVIEN® in patients with chronic diabetic macular edema (DME) who were insufficiently responsive to prior therapies.
Alves, D +5 more
core +3 more sources
Therapeutic Advances in Ophthalmology, 2020 Introduction: The ILUVIEN ® (fluocinolone acetonide) Clinical Evidence in Portugal (ICE-PT) study is a retrospective, multicenter, observational study evaluating the effectiveness and safety of the FAc implant in patients with diabetic macular edema ...
Angela Carneiro +3 more
doaj +2 more sources